Keywords: gsk, dutasteride, bph, cleared, usa, towards, end

GSK's dutasteride for BPH cleared in USA

Article | 28 December 2001

Print This

Towards the end of last year, GlaxoSmithKline was awarded approval inthe USA to market its novel 5-alpha reductase inhibitor dutasteride ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in